Harbor International Compounders ETF
OSEA - ETF AI Analysis
Top Page
Harbor International Compounders ETF (OSEA)
OSEA, the Harbor International Compounders ETF, earns a solid overall rating thanks to several high-quality global leaders like TSMC and AstraZeneca, which bring strong financial performance, positive earnings outlooks, and strategic positioning in advanced technologies and healthcare. Other major holdings such as ASML, Deutsche Boerse, and Siemens add to this strength with robust revenue and profit growth, though some names like SAP and RELX face bearish or mixed technical signals and potentially rich valuations that slightly weigh on the fund’s appeal. The main risk factor is its concentration in a relatively small set of large international companies, where high valuations and occasional overbought or bearish technical conditions could increase volatility.
OSEA vs. SPDR S&P 500 ETF (SPY)
- AUM
- 375.37M
- Region
- Global Ex-U.S.
- Expense Ratio
- 0.55%
- Beta
- 0.76
- Issuer
- Harbor
- Inception Date
- Sep 06, 2022
- Dividend Yield
- 1.26%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
OSEA Summary
Harbor International Compounders ETF (OSEA) is an actively managed fund that invests in strong companies from around the world rather than tracking a specific index. It focuses on international businesses that steadily grow their profits and reinvest them, aiming for long-term growth. The fund holds well-known names like Taiwan Semiconductor (TSMC), ASML, SAP, and AstraZeneca, and spreads investments across many countries and sectors, which can help with diversification. However, because it owns stocks from global markets, its value can go up and down with changes in the world economy and stock markets.
How much will it cost me?
This ETF has an expense ratio of 0.55%, which means you’ll pay about $5.50 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because this fund is actively managed, with professionals selecting and overseeing a focused portfolio of international companies.
What would affect this ETF?
OSEA could benefit if global growth outside the U.S. remains strong, especially for its major technology and health care holdings like TSMC, ASML, and AstraZeneca, and if steady cash flows from financials, utilities, and consumer companies support long-term compounding. On the downside, weaker international economies, higher interest rates that pressure growth stocks, or regulatory changes affecting foreign tech and financial firms could hurt performance, and its focus outside the U.S. means it is also exposed to currency swings and regional political risks.
OSEA Top 10 Holdings
OSEA is leaning heavily into international growth engines, with chip giants TSMC and ASML acting as the main power plants—despite some recent wobbling, their longer-term strength is still a key driver for the fund. European names like SAP and Deutsche Boerse are rising and help steady performance, while Tesco and Compass add a more defensive, consumer-focused backbone that’s been quietly supportive. AstraZeneca has been more mixed, losing a bit of steam lately. Overall, the ETF is tilted toward non-U.S. tech and quality European compounders, giving it broad global ex-U.S. exposure.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 TSM | TSMC | 6.67% | $25.14M | $1.89T | 39.53% | 81Outperform |
 NL:ASML | ASML Holding NV | 5.27% | $19.87M | EUR 536.23B | 54.38% | 76Outperform |
 DE:DB1 | Deutsche Boerse | 4.57% | $17.22M | EUR 58.20B | 56.24% | 76Outperform |
 DE:SAP | SAP SE | 4.46% | $16.82M | EUR 246.30B | -2.68% | 66Neutral |
 HDB | Hdfc Bank | 4.54% | $17.11M | $132.71B | -29.52% | 73Outperform |
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
 GB:TSCO | Tesco plc | 4.27% | $16.08M | GBP 34.12B | 21.94% | 74Outperform |
 GB:REL | RELX plc | 4.25% | $16.00M | GBP 52.04B | -3.73% | 76Outperform |
 HK:1299 | AIA Group | 3.88% | $14.63M | HKD 816.35B | -5.77% | 72Outperform |
 DE:SIE | Siemens | 3.92% | $14.76M | EUR 211.15B | 12.50% | 74Outperform |
OSEA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For OSEA, the sentiment is Negative. The current price of 29.77 is below the 20-day moving average (MA) of 29.86, above the 50-day MA of 29.65, and below the 200-day MA of 30.12, indicating a neutral trend. The MACD of 0.08 indicates Negative momentum. The RSI at 49.24 is Neutral, neither overbought nor oversold. The STOCH value of 42.12 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for OSEA.
OSEA Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| OSEA | $29.77 | $33.00(10.86% Upside) | $375.37M | 0.55% | 71Outperform |
 JDVI | $39.08 | $45.77(17.11% Upside) | $809.64M | 0.69% | 60Neutral |
 BRIE | $29.75 | $39.36(32.29% Upside) | $794.40M | 0.34% | 64Neutral |
 QLTI | $28.31 | $34.17(20.71% Upside) | $289.87M | 0.60% | 61Neutral |
 BAIV | $28.91 | $31.82(10.07% Upside) | $196.93M | 0.60% | 60Neutral |
 IDYN | $29.77 | $34.80(16.89% Upside) | $112.98M | 0.46% | 59Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| OSEA | Harbor International Compounders ETF | 29.77 | -0.14 | -0.48% | |
| JDVI | John Hancock Disciplined Value International Select ETF | 39.08 | 5.11 | 15.03% | |
| BRIE | MFS Blended Research International Equity ETF | 29.75 | 4.27 | 16.75% | |
| QLTI | GMO International Quality ETF | 28.30 | 2.56 | 9.95% | |
| BAIV | Brown Advisory International Value Select ETF | 28.91 | 3.32 | 12.98% | |
| IDYN | iShares International Equity Factor Rotation Active ETF | 29.77 | 2.80 | 10.39% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.